Chiral chromatography-tandem mass spectrometry applied to the determination of pro-resolving lipid mediators

Journal of Chromatography A

Volumn 1360, Issue , 2014, Pages 150-163

  Homann, Julia ^a   Lehmann, Christoph ^a,b   Kahnt, Astrid S ^a   Steinhilber, Dieter ^a   Parnham, Michael J ^b   Geisslinger, Gerd ^a,b   Ferreirós, Nerea ^a  

^a GOETHE UNIVERSITY   (Germany)

^b FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

Author keywords

Chiral chromatography tandem mass spectrometry; Lipoxin; Maresin; Pro resolving lipid mediators; Protectin; Resolvin

Indexed keywords

LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL); UNSATURATED FATTY ACIDS;

LIPID MEDIATORS; LIPOXIN; MARESIN; PROTECTIN; RESOLVIN; TANDEM MASS SPECTROMETRY;

CELL CULTURE;

6 EPI LIPOXIN A4; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; HYDROXYDOCOSAHEXAENOIC ACID; LIPID; LIPOXENE A; LIPOXIN; LIPOXIN A; LIPOXIN B; MARESIN; PRO RESOLVING LIPID MEDIATOR; RESOLVIN D1; RESOLVIN D2; UNCLASSIFIED DRUG; 15 HYDROXYICOSATETRAENOIC ACID;

ARTICLE; CALIBRATION; CHIRAL CHROMATOGRAPHY; CONTROLLED STUDY; CULTURE MEDIUM; FREEZE THAWING; HUMAN; HUMAN CELL; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; NEUTROPHIL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SUPERNATANT; TANDEM MASS SPECTROMETRY; THROMBOCYTE; CHEMISTRY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; PROCEDURES; STEREOISOMERISM; ANALYTE RECOVERY; ANALYTE STABILITY; ANALYTICAL PARAMETERS; CELL STIMULATION; LEUKOCYTE; LIPID ANALYSIS; LIPOGENESIS; MATRIX EFFECTS; PROCESS OPTIMIZATION; RELIABILITY;

CHROMATOGRAPHY, LIQUID; HUMANS; LIMIT OF DETECTION; LIPOXINS; LIQUID-LIQUID EXTRACTION; NEUTROPHILS; STEREOISOMERISM; TANDEM MASS SPECTROMETRY;

EID: 84906789022     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.07.068     Document Type: Article

References (42)

1. Serhan C.N. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 2007, 25:101-137.
2. Serhan C.N., Dalli J., Karamnov S., Choi A., Park C.K., Xu Z.Z., Ji R.R., Zhu M., Petasis N.A. Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. FASEB J. 2012, 26:1755-1765.
3. Xu Z.Z., Ji R.R. Resolvins are potent analgesics for arthritic pain. Br. J. Pharmacol. 2011, 164:274-277.
4. Xu Z.Z., Zhang L., Liu T., Park J.Y., Berta T., Yang R., Serhan C.N., Ji R.R. Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat. Med. 2010, 16:592-597. 591p following 597.
5. Bang S., Yoo S., Yang T.J., Cho H., Kim Y.G., Hwang S.W. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br. J. Pharmacol. 2010, 161:707-720.
6. Chiang N., Fredman G., Backhed F., Oh S.F., Vickery T., Schmidt B.A., Serhan C.N. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012, 484:524-528.
7. Sodin-Semrl S., Taddeo B., Tseng D., Varga J., Fiore S. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 2000, 164:2660-2666.
8. Haworth O., Levy B.D. Endogenous lipid mediators in the resolution of airway inflammation. Eur. Respir. J. 2007, 30:980-992.
9. Huang L., Wang C.F., Serhan C.N., Strichartz G. Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 2011, 152:557-565.
10. Bannenberg G., Serhan C.N. Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim. Biophys. Acta 2010, 1801:1260-1273.
11. Chiang N., Arita M., Serhan C.N. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:163-177.
12. Tejera N., Boeglin W.E., Suzuki T., Schneider C. COX-2-dependent and -independent biosynthesis of dihydroxy-arachidonic acids in activated human leukocytes. J. Lipid. Res. 2012, 53:87-94.
13. Serhan C.N., Nicolaou K.C., Webber S.E., Veale C.A., Dahlen S.E., Puustinen T.J., Samuelsson B., Lipoxin A. Stereochemistry and biosynthesis. J. Biol. Chem. 1986, 261:16340-16345.
14. Hong S., Gronert K., Devchand P.R., Moussignac R.L., Serhan C.N. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol. Chem. 2003, 278:14677-14687.
15. Sun Y.P., Oh S.F., Uddin J., Yang R., Gotlinger K., Campbell E., Colgan S.P., Petasis N.A., Serhan C.N. Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 2007, 282:9323-9334.
16. Serhan C.N., Gotlinger K., Hong S., Lu Y., Siegelman J., Baer T., Yang R., Colgan S.P., Petasis N.A. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 2006, 176:1848-1859.
17. Serhan C.N., Yang R., Martinod K., Kasuga K., Pillai P.S., Porter T.F., Oh S.F., Spite M. Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J. Exp. Med. 2009, 206:15-23.
18. Dalli J., Zhu M., Vlasenko N.A., Deng B., Haeggstrom J.Z., Petasis N.A., Serhan C.N. The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype. FASEB J. 2013, 27:2573-2583.
19. Claria J., Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9475-9479.
20. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., Yang R., Petasis N.A., Serhan C.N. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 2005, 201:713-722.
21. Serhan C.N., Fredman G., Yang R., Karamnov S., Belayev L.S., Bazan N.G., Zhu M., Winkler J.W., Petasis N.A. Novel proresolving aspirin-triggered DHA pathway. Chem. Biol. 2011, 18:976-987.
22. Takano T., Fiore S., Maddox J.F., Brady H.R., Petasis N.A., Serhan C.N. Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 1997, 185:1693-1704.
23. Claria J., Lee M.H., Serhan C.N. Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation. Mol. Med. 1996, 2:583-596.
24. Miller D.K., Sadowski S., DeSousa D., Maycock A.L., Lombardo D.L., Young R.N., Hayes E.C. Development of enzyme-linked immunosorbent assays for measurement of leukotrienes and prostaglandins. J. Immunol. Methods 1985, 81:169-185.
25. Sekizawa A., Farina A., Sugito Y., Matsuoka R., Iwasaki M., Saito H., Okai T. Proteinuria and hypertension are independent factors affecting fetal DNA values: a retrospective analysis of affected and unaffected patients. Clin. Chem. 2004, 50:221-224.
26. Lu Y., Hong S., Gotlinger K., Serhan C.N. Lipid mediator informatics and proteomics in inflammation resolution. ScientificWorldJournal 2006, 6:589-614.
27. Steinhilber D., Herrmann T., Roth H.J. Separation of lipoxins and leukotrienes from human granulocytes by high-performance liquid chromatography with a Radial-Pak cartridge after extraction with an octadecyl reversed-phase column. J. Chromatogr. 1989, 493:361-366.
28. Serhan C.N., Sheppard K.A. Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J. Clin. Invest. 1990, 85:772-780.
29. U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), http://www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.
30. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use, http://www.ich.org/fileadmin/Public_Web_Site/.
31. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
32. Bonfiglio R., King R.C., Olah T.V., Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 1999, 13:1175-1185.
33. Peng L., Jayapalan S., Chankvetadze B., Farkas T. Reversed-phase chiral HPLC and LC/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases. J. Chromatogr. A 2010, 1217:6942-6955.
34. Le Faouder P., Baillif V., Spreadbury I., Motta J.P., Rousset P., Chene G., Guigne C., Terce F., Vanner S., Vergnolle N., Bertrand-Michel J., Dubourdeau M., Cenac N. LC-MS/MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013, 932:123-133.
35. Shinde D.D., Kim K.B., Oh K.S., Abdalla N., Liu K.H., Bae S.K., Shon J.H., Kim H.S., Kim D.H., Shin J.G. LC-MS/MS for the simultaneous analysis of arachidonic acid and 32 related metabolites in human plasma: basal plasma concentrations and aspirin-induced changes of eicosanoids. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2012, 911:113-121.
36. Mas E., Croft K.D., Zahra P., Barden A., Mori T.A. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin. Chem. 2012, 58:1476-1484.
37. Claria J., Nguyen B.T., Madenci A.L., Ozaki C.K., Serhan C.N. Diversity of lipid mediators in human adipose tissue depots. Am. J. Physiol. Cell Physiol. 2013, 304:C1141-C1149.
38. Dalli J., Serhan C.N. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 2012, 120:e60-e72.
39. Massey K.A., Nicolaou A. Lipidomics of oxidized polyunsaturated fatty acids. Free Radic. Biol. Med. 2013, 59:45-55.
40. Miyata J., Fukunaga K., Iwamoto R., Isobe Y., Niimi K., Takamiya R., Takihara T., Tomomatsu K., Suzuki Y., Oguma T., Sayama K., Arai H., Betsuyaku T., Arita M., Asano K. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. J Allergy Clin. Immunol. 2013, 131:353-360. e351-352.
41. Giera M., Ioan-Facsinay A., Toes R., Gao F., Dalli J., Deelder A.M., Serhan C.N., Mayboroda O.A. Lipid and lipid mediator profiling of human synovial fluid in rheumatoid arthritis patients by means of LC-MS/MS. Biochim. Biophys. Acta 2012, 1821:1415-1424.
42. Yang J., Eiserich J.P., Cross C.E., Morrissey B.M., Hammock B.D. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients. Free Radic. Biol. Med. 2012, 53:160-171.